Profound Medical Corp Sustainability Reports
A commercial-stage medical technology company that develops and markets customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue. Its platform technologies combine real-time MRI, thermal ultrasound, and closed-loop temperature feedback control to treat prostate disease and other clinical indications.
Sector: Manufacturing
Country: Canada
Exchange: Toronto Stock Exchange
7 reports from 2016 to 2024
- Profound Medical Corp 2024 Report on Fighting Against Forced Labour and Child Labour in Supply Chains Act
- Profound Medical Corp 2024 Form 10-K
- Profound Medical Corp 2023 Consolidated Financial Statements
- Profound Medical Corp 2022 Consolidated Financial Statements
- Profound Medical Corp 2021 Consolidated Financial Statements